Prognostic Factors Keeping Track for COVID-19 Pneumonia
NCT04324684 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 198
Last updated 2020-05-14
Summary
It has been reported that nearly half of the patients who are hospitalized for Covid-19 pneumonia have on admission old age or comorbidities.
In particular, hypertension was present in 30% of the cases, diabetes in 19%, coronary heart disease in 8% and chronic obstructive lung disease in 3% of the patients.
Amazingly, in the two major studies published in the Lancet (Zhou F et al Lancet 2020) and in the New England Journal of Medicine (Guan W et al 2020), the weight of the subjects as well their body mass index (BMI) were omitted. However, obesity, alone or in association with diabetes, can be a major predisposition factor for Covid-19 infection.
The primary end-point of our prospective, observational study is to assess the recovery rate in patients with diagnosis of Covid-19 pneumonia. Among the other secondary end-points, we intend to find the predictors of the time to clinical improvement or hospital discharge in patients affected by Covid-19 pneumonia.
Conditions
- Pneumonia, Viral
- Hypertension
- Diabetes Mellitus
- Obesity
- Cardiovascular Diseases
- Obstructive Lung Disease
Sponsors & Collaborators
-
Catholic University of the Sacred Heart
lead OTHER
Principal Investigators
-
Geltrude Mingrone, MD PhD · Fondazione Policlinico Universitario A. Gemelli, IRCCS
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-31
- Primary Completion
- 2020-05-07
- Completion
- 2020-05-07
Countries
- Italy
Study Locations
More Related Trials
-
Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV.
NCT04552340 ·Status: UNKNOWN
-
A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae
NCT06006884 ·Status: RECRUITING
-
Late Respiratory Consequences of SARS-CoV-2 Pneumonia
NCT05812196 ·Status: RECRUITING
-
Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease
NCT04407169 ·Status: COMPLETED
-
Screening for Chronic Obstructive Pulmonary Disease in Patients With Acute Coronary Syndromes
NCT02324660 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular Risk and Chronic Obstructive Pulmonary Disease
NCT03014609 ·Status: RECRUITING
-
Prevention of Chronic Lung Disease (CLD - Prevention Study)
NCT06559670 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pulmonary Fibrosis After Severe COVID-19 Pneumonia
NCT06423560 ·Status: COMPLETED
-
Cognitive Impairment in COPD Patients
NCT04394299 ·Status: UNKNOWN
-
Assessment of Severity and Prognosis in Elderly Patients With COPD and Complex Chronic Comorbidities
NCT01893918 ·Status: UNKNOWN
-
Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic
NCT04441502 ·Status: ACTIVE_NOT_RECRUITING
-
Burden of Hospitalized Pneumonia in Korea COPD Population
NCT03046134 ·Status: UNKNOWN
-
Diagnostic Values of C-reactive Protein and Procalcitonin in Predicting Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
NCT03923803 ·Status: UNKNOWN
-
Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease
NCT06072690 ·Status: RECRUITING
-
Predictors of Hospital Readmission for Chronic Obstructive Pulmonary Disease Patients
NCT06348966 ·Status: NOT_YET_RECRUITING
-
Persistent Dyspnea in Post COVID_19 and Pulmonary Function
NCT05228678 ·Status: UNKNOWN
-
Impact of COVID-19 on Lung Function in COPD Patients.
NCT05770440 ·Status: RECRUITING
-
Best Clinical Endpoints That Likely Induce Worse Prognosis in Interstitial Lung Diseases
NCT03400839 ·Status: UNKNOWN
-
Optimised Lung Cancer Screening to Prevent Cardiovascular and Pulmonary Diseases Coupled With Primary Prevention
NCT04315766 ·Status: UNKNOWN
-
Prognostic Features for Mortality in Young Adults With Pneumonia
NCT00845312 ·Status: COMPLETED
-
Low-dose CT for Diagnosis of Pneumonia in COPD Exacerbations and Comparison of the Inflammatory Profile.
NCT02264483 ·Status: UNKNOWN
-
Long COVID and Post-exertional Pulmonary Diffusion
NCT05430503 ·Status: COMPLETED
-
Is COPD a Risk Factor for Cardiovascular Disease?
NCT02162095 ·Status: COMPLETED
-
Sarcopenia in Chronic Lung Diseases
NCT06280443 ·Status: RECRUITING
-
Evaluation of Plasma Sphingosine-1-Phosphate as A Diagnostic and Prognostic Biomarkers of Community-Acquired Pneumonia
NCT03473119 ·Status: UNKNOWN